UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057903
Receipt number R000066189
Scientific Title Systematic Review and Meta-analysis of Diagnostic Accuracy of Deep Learning Using Ultra-Widefield Fundus Imaging for Retinal Detachment
Date of disclosure of the study information 2025/05/30
Last modified on 2025/05/24 11:43:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Meta-analysis of Diagnostic Accuracy of Deep Learning Based on Ultra-Widefield Fundus Imaging for Retinal Detachment

Acronym

DL-UWF Meta-analysis for Retinal Detachment Diagnosis

Scientific Title

Systematic Review and Meta-analysis of Diagnostic Accuracy of Deep Learning Using Ultra-Widefield Fundus Imaging for Retinal Detachment

Scientific Title:Acronym

Systematic Review of DL*UWF for RD Diagnosis

Region

Japan


Condition

Condition

Retinal Detachment

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To systematically collect and synthesize existing studies on the automated diagnosis of retinal detachment using deep learning applied to ultra-widefield fundus imaging, and to evaluate diagnostic performance metrics such as sensitivity, specificity, and area under the curve (AUC).

Basic objectives2

Others

Basic objectives -Others

To evaluate the diagnostic performance of deep learning algorithms for retinal detachment detection, thereby providing a basis for discussing their potential applicability and future clinical implementation in ophthalmology.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sensitivity and specificity of deep learning algorithms using ultra-widefield fundus images for the diagnosis of retinal detachment, based on the assessment at the time of diagnosis in each included study

Key secondary outcomes

Key secondary outcomes include the area under the summary receiver operating characteristic curve (AUC) at the time of diagnosis, the diagnostic odds ratio (DOR), between-study heterogeneity assessed by the I^2 statistic, and risk of bias evaluated using the QUADAS-2 tool.


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

This meta-analysis includes studies that evaluate the diagnostic accuracy - specifically sensitivity and specificity - of deep learning algorithms using ultra-widefield fundus images for the detection of retinal detachment. Eligible study designs include case-control, cross-sectional, prospective, and retrospective observational studies. Studies must report sufficient data to allow calculation of diagnostic accuracy metrics (true positives, false positives, false negatives, true negatives). While peer-reviewed original articles are primarily targeted, conference abstracts may also be included if they contain adequate diagnostic information.

Key exclusion criteria

Studies that report only sensitivity or specificity, or that lack sufficient data to calculate diagnostic accuracy metrics, will be excluded. In addition, studies suspected of using duplicate datasets and non-original articles such as case reports, reviews, and editorials will also be excluded.

Target sample size



Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Mizuki

Organization

Yokohama City University Hospital

Division name

Department of Ophthalmology

Zip code

236-0004

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan

TEL

0457872683

Email

mizuki.yuk.xj@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Mizuki

Organization

Yokohama City University Hospital

Division name

Department of Ophthalmology

Zip code

236-0004

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan

TEL

0457872683

Homepage URL


Email

mizuki.yuk.xj@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University

Institute

Department

Personal name

Yuki Mizuki


Funding Source

Organization

Yokohama City University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City University School of Medicine Department of Ophthalmology and Visual Science

Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan

Tel

0457872683

Email

mizuki.yuk.xj@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

Kanagawa


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 05 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 05 Month 19 Day

Date of IRB


Anticipated trial start date

2025 Year 05 Month 24 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study will be conducted in accordance with the PRISMA-DTA guidelines and the Cochrane Handbook, and is planned to be registered in both the UMIN Clinical Trials Registry and PROSPERO. The findings are expected to serve as foundational evidence for evaluating the potential implementation of artificial intelligence technologies in ophthalmic practice.


Management information

Registered date

2025 Year 05 Month 19 Day

Last modified on

2025 Year 05 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066189